187 related articles for article (PubMed ID: 20484558)
1. Phosphatase of regenerating liver-1 promotes cell migration and invasion and regulates filamentous actin dynamics.
Nakashima M; Lazo JS
J Pharmacol Exp Ther; 2010 Aug; 334(2):627-33. PubMed ID: 20484558
[TBL] [Abstract][Full Text] [Related]
2. PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells.
Achiwa H; Lazo JS
Cancer Res; 2007 Jan; 67(2):643-50. PubMed ID: 17234774
[TBL] [Abstract][Full Text] [Related]
3. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
Fiordalisi JJ; Keller PJ; Cox AD
Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
[TBL] [Abstract][Full Text] [Related]
4. Elevated phosphatase of regenerating liver 3 (PRL-3) promotes cytoskeleton reorganization, cell migration and invasion in endometrial stromal cells from endometrioma.
Zhan H; Ma J; Ruan F; Bedaiwy MA; Peng B; Wu R; Lin J
Hum Reprod; 2016 Apr; 31(4):723-33. PubMed ID: 26874360
[TBL] [Abstract][Full Text] [Related]
5. Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition.
Lin SY; Lee YX; Yu SL; Chang GC; Chen JJ
Oncotarget; 2016 Apr; 7(16):21799-811. PubMed ID: 26967563
[TBL] [Abstract][Full Text] [Related]
6. Metastasis-associated phosphatase PRL-2 regulates tumor cell migration and invasion.
Wang Y; Lazo JS
Oncogene; 2012 Feb; 31(7):818-27. PubMed ID: 21765462
[TBL] [Abstract][Full Text] [Related]
7. PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition.
Wang H; Quah SY; Dong JM; Manser E; Tang JP; Zeng Q
Cancer Res; 2007 Apr; 67(7):2922-6. PubMed ID: 17409395
[TBL] [Abstract][Full Text] [Related]
8. Phosphatase of regenerating liver-3 promotes migration and invasion by upregulating matrix metalloproteinases-7 in human colorectal cancer cells.
Lee SK; Han YM; Yun J; Lee CW; Shin DS; Ha YR; Kim J; Koh JS; Hong SH; Han DC; Kwon BM
Int J Cancer; 2012 Aug; 131(3):E190-203. PubMed ID: 22131018
[TBL] [Abstract][Full Text] [Related]
9. The metastasis-promoting phosphatase PRL-3 shows activity toward phosphoinositides.
McParland V; Varsano G; Li X; Thornton J; Baby J; Aravind A; Meyer C; Pavic K; Rios P; Köhn M
Biochemistry; 2011 Sep; 50(35):7579-90. PubMed ID: 21806020
[TBL] [Abstract][Full Text] [Related]
10. Downregulating PRL-3 inhibit migration and invasion of lung cancer cell via RhoA and mDia1.
Jian M; Nan L; Guocheng J; Qingfu Z; Xueshan Q; Enhua W
Tumori; 2012; 98(3):370-6. PubMed ID: 22825514
[TBL] [Abstract][Full Text] [Related]
11. PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasion.
Gari HH; DeGala GD; Ray R; Lucia MS; Lambert JR
Cancer Lett; 2016 Oct; 380(2):505-512. PubMed ID: 27452906
[TBL] [Abstract][Full Text] [Related]
12. PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways.
Luo Y; Liang F; Zhang ZY
Biochemistry; 2009 Mar; 48(8):1838-46. PubMed ID: 19199380
[TBL] [Abstract][Full Text] [Related]
13. Phosphatase of Regenerating Liver-1 (PRL-1) Regulates Actin Dynamics During Immunological Synapse Assembly and T Cell Effector Function.
Castro-Sánchez P; Ramirez-Munoz R; Martín-Cófreces NB; Aguilar-Sopeña O; Alegre-Gomez S; Hernández-Pérez S; Reyes R; Zeng Q; Cabañas C; Sánchez-Madrid F; Roda-Navarro P
Front Immunol; 2018; 9():2655. PubMed ID: 30515156
[TBL] [Abstract][Full Text] [Related]
14. Expression of PRL-3 regulates proliferation and invasion of breast cancer cells in vitro.
Radke I; Götte M; Smollich M; Scharle N; Kiesel L; Wülfing P
Arch Gynecol Obstet; 2017 Dec; 296(6):1153-1160. PubMed ID: 28980126
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of phosphatase of regenerating liver gene family in non-small cell lung cancer.
Hwang JJ; Min SH; Sin KH; Heo YS; Kim KD; Yoo OJ; Lee SH
Oncol Rep; 2012 Feb; 27(2):535-40. PubMed ID: 21993571
[TBL] [Abstract][Full Text] [Related]
16. PRL phosphatases as potential molecular targets in cancer.
Stephens BJ; Han H; Gokhale V; Von Hoff DD
Mol Cancer Ther; 2005 Nov; 4(11):1653-61. PubMed ID: 16275986
[TBL] [Abstract][Full Text] [Related]
17. PRL-3 promotes migration and invasion and is associated with poor prognosis in salivary adenoid cystic carcinoma.
Dong Q; Ding X; Chang B; Wang H; Wang A
J Oral Pathol Med; 2016 Feb; 45(2):111-8. PubMed ID: 26041460
[TBL] [Abstract][Full Text] [Related]
18. PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells.
Liu H; Al-aidaroos AQ; Wang H; Guo K; Li J; Zhang HF; Zeng Q
BMC Cancer; 2013 Feb; 13():80. PubMed ID: 23418787
[TBL] [Abstract][Full Text] [Related]
19. Down-modulation of keratin 8 phosphorylation levels by PRL-3 contributes to colorectal carcinoma progression.
Mizuuchi E; Semba S; Kodama Y; Yokozaki H
Int J Cancer; 2009 Apr; 124(8):1802-10. PubMed ID: 19115206
[TBL] [Abstract][Full Text] [Related]
20. PRL-3 and PRL-1 promote cell migration, invasion, and metastasis.
Zeng Q; Dong JM; Guo K; Li J; Tan HX; Koh V; Pallen CJ; Manser E; Hong W
Cancer Res; 2003 Jun; 63(11):2716-22. PubMed ID: 12782572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]